Brussels and Washington have unveiled the specifics of a major EU-US trade agreement, delivering a considerable boon to Ireland’s pharmaceutical sector. Under the terms, the United States will impose a
Brussels and Washington have unveiled the specifics of a major EU-US trade agreement, delivering a considerable boon to Ireland’s pharmaceutical sector. Under the terms, the United States will impose a
Wes Streeting, the new health secretary, has escalated his confrontation with leading pharmaceutical firms over the soaring cost of medicines and its impact on the UK’s broader life sciences sector.
Eli Lilly, the pharmaceutical giant behind the popular weight loss injection Mounjaro, has announced a substantial price hike for the medication due to take effect in the UK from September.
The UK market for private weight loss drugs is bracing itself for seismic change as Eli Lilly announces dramatic price increases for its popular Mounjaro injections. Over 1.5 million Britons
The UK market for prescription weight loss injections has witnessed dramatic upheaval, prompted by a sharp price increase for Mounjaro, currently the nation’s most widely used weight loss jab. From
Shares in Novo Nordisk climbed over five per cent on the Copenhagen exchange after the Danish pharmaceuticals firm received crucial approval from the United States Food and Drug Administration for
A major rise in the cost of Mounjaro is set to impact more than a million weight loss patients across Britain next month amid an international dispute over medicine prices.
Scientists at the Massachusetts Institute of Technology have harnessed artificial intelligence to design two innovative antibiotics capable of combating superbugs such as MRSA. This breakthrough could usher in a new
A new oral medication weight loss, orforglipron, has shown promising results in a landmark trial, marking a significant step for obesity treatment in the UK. Developed by Eli Lilly, orforglipron
Shares in European drug companies slumped to a four-month low on Wednesday, after US President Donald Trump reiterated his intention to impose tariffs on pharmaceutical imports in a bid to
Novo Nordisk, the Danish pharmaceutical titan known for its diabetes and weight loss treatments Ozempic and Wegovy, now faces a period of significant turbulence. The company has issued a stark
Alzheimers patients can extend cognitive health for years with breakthrough drugs ||| Groundbreaking trial results have revealed that radical new treatments can effectively stall the progression of Alzheimer’s disease for
AstraZeneca has reported record second quarter revenues, propelled by robust oncology sales and expansion in the United States, surpassing City expectations. The pharmaceutical company’s total revenue rose by 11 per
A breakthrough in the battle against Alzheimer’s disease may be on the horizon after promising trial results revealed the potential of an innovative drug developed by Roche. Trontinemab has delivered
AstraZenecas chief executive has described the pharmaceutical giant as a very American company following rising speculation about a potential shift of its main stock market listing from London to New
AstraZeneca has announced an ambitious plan to invest £50 billion in the United States by the end of the decade. This significant move is expected to bolster the company’s manufacturing






